|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
DRUG METABOLISM/TRANSPORT |
From the Pharmacy, Hôpital Hautepierre, Strasbourg, France, and the Institute of Bacteriology, Strasbourg, France.
This review focuses on the published data regarding the molecular determinants (enzymes, transporters, orphan nuclear receptors) of Catharanthus (vinca) alkaloids pharmacokinetics in humans. The clinical impact of these determinants (drug disposition, drug-drug interactions) is also discussed.
Key Words: Catharanthus alkaloids vinblastine vincristine vindesine vinorelbine CYP450 drug transporters orphan nuclear receptors drug-drug interactions
Address for reprints: Address for correspondence: Dominique Levêque, Pharmacy-Pharmacology, Hôpital Hautepierre, Avenue Molière, 67000 Strasbourg, France; e-mail: dominique.leveque{at}chru-strasbourg.fr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
P. P. Fulco, L. Hynicka, and D. Rackley Raltegravir-Based HAART Regimen in a Patient with Large B-Cell Lymphoma Ann. Pharmacother., February 1, 2010; 44(2): 377 - 382. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |